Heparan sulfate (HS) chains bind and activate fibroblast growth factor-2 (FGF-2
INTRODUCTION
Vascular endothelial cells proliferate strongly depending on endogenous fibroblast growth factor-2 (FGF-2) when they repair damaged cell layers. The growth factor acts on the cells primarily through cell surface high affinity tyrosine kinase receptors; 1) however, their activity is modulated by heparan sulfate proteoglycans (HSPGs). [2] [3] [4] Proteoglycans (PGs) are a heterogeneous group of proteins that have anionic glycosaminoglycan (GAG) side chains such as heparan sulfate (HS) and chondroitin/dermatan sulfate (CS/DS) that consist of alternating hexuronic acid and hexosamine covalently bound to a core protein. 5 ) FGF-2 is bound to a specific HS sequence of a hexasaccharide containing 2-O-sulfated iduronic acid [IdoA(2S)] and N-sulfated glucosamine (GlcNS). 6 ) A dodecasaccharide containing 6-O-sulfated GlcNS [GlcNS(6S)] residues as well as the binding region is required for receptor signaling. 7) The PG whose HS chains regulate the activity of FGF-2 in vitro 8) and in vivo 9, 10) is a large HSPG perlecan. However, the ability of HS chains to activate FGF-2, which relies on the primary sequence, structure and organization of HS chains, is changeable depending on the cell type and differentiation state. 10, 11) Lead is a toxic heavy metal that has been shown to induce vascular disorders such as atherosclerosis in epidemiological and experimental studies. [12] [13] [14] [15] [16] Our cell culture studies indicate that the metal influences fibrinolytic activity and the monolayer maintenance of vascular endothelial cells, 17) important events in the initiation of atherosclerosis. 18) In addition, lead inhibits the repair of wounded monolayers of endothelial cells by induction of a lower cell response to endogenous FGF-2 as a result of inhibition of perlecan core protein synthesis without a change of HS chain length. 19) However, it is unclear whether or not lead changes the composition of HS chains in perlecan molecules of vascular endothelial cells.
In the present study, growing cultures of bovine aortic endothelial cells were exposed to lead, and the disaccharide units of HS and CS/DS chains obtained from the cell layer and the conditioned me-*To whom correspondence should be addressed: Department of Environmental Health, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa-machi, Kanazawa 920-1181, Japan. Tel. & Fax: +81-76-229-6208; E-mail: t-kaji@ hokuriku-u.ac.jp dium were separately analyzed by fluorophore-assisted carbohydrate electrophoresis (FACE) after enzymatic digestion. Arthrobacter aurescens) and ∆-disaccharide standards were from Seikagaku (Tokyo, Japan). Proteinase K (fungal) was purchased from Invitrogen (Carlsbad, CA, U.S.A.). DEAE-Sephacel, benzamidine, phenylmethanesulfonyl fluoride, Tris base, benzamidine, sodium cyanoborohydride (95% pure), sodium acetate, ammonium hydroxide, acetic acid, dimethylsulfoxide, chondroitin disaccharide ∆di-6S and D-galactose 6-sulfate (gal6S) were from Sigma Aldrich (St. Louis, MO, U.S.A.). Lead nitrate and other reagents were from Nacalai Tesque (Kyoto, Japan). Cell Culture and PG Isolation ---Vascular endothelial cells were cultured in DMEM supplemented with 10% fetal bovine serum in 100 mm dishes at 37°C in a humid atmosphere of 5% CO 2 in air until confluence. They were then transferred into 100 mm dishes at 1 × 10 4 cells/cm 2 and cultured for 24 hr in DMEM supplemented with 10% fetal bovine serum ("growing cultures"). The medium was discarded and the cell layer was washed twice with serum-free ASF 301 medium. The growing cultures of endothelial cells were then incubated at 37°C for 48 hr in fresh serum-free ASF 301 medium with lead nitrate (2 µM). After incubation, the conditioned medium was harvested and solid urea was added to a concentration of 8 M ("the medium extract"). The cell layer was washed twice with ice-cold Ca, Mgfree phosphate-buffered saline and extracted with 8 M urea solution containing 0.1 M 6-aminohexanoic acid, 5 mM benzamidine, 10 mM N-ethylmaleimide, 2 mM EDTA, 0.1 M phenylmethanesulfonyl fluoride, 0.1 M NaCl, 50 mM Tris base and 2% Triton X-100 (pH 7.5) at 4°C for 15 min; the cell layer was harvested by scraping with a rubber policeman ("the cell extract"). The medium and cell extracts were purified and concentrated by ion exchange chromatography on DEAE-Sephacel in 8 M urea buffer (8 M urea, 2 mM EDTA, 0.5% Triton X-100 and 50 mM Tris base, pH 7.5) containing 0.25 M NaCl and eluted with 8 M urea buffer containing 3 M NaCl. Enzymatic Digestion and FACE ---DEAESephacel-purified PGs were precipitated with 3.5 volumes of 1.3% potassium acetate in 95% ethanol. Core proteins of the PGs were digested at 60°C for 18 hr with 0.8 mg/ml proteinase K in 0.1 M sodium acetate buffer (pH 7.2). After inactivation of the proteinase at 100°C for 10 min, buffer salt and protein digests were removed by centrifugation of the digests in Microcon 3. The GAGs on the filter were recovered in 0.1 M ammonium acetate (pH 7.3) and digested at 37°C for 18 hr with both 0.2 U/ml chondroitinase ABC and 1 U/ml of chondroitinase AC II. The CS/DS hydrolase products were recovered with Microcon 3 and dried for further processing. The undigested materials on the filter (HS chains) were recovered in 0.1 M ammonium acetate (pH 7.0) containing 0.01% bovine serum albumin and digested at 37°C for 8 hr with both 0.03 U/ml heparitinase I and II. The HS hydrolase products were recovered with Microcon 3 and then dried. The dried HS and CS/DS samples were fluorotagged with 0.1 M 2-aminoacridone hydrochloride. The fluorotagged-CS/DS hydrolase products were separated on the separating gels (20% acrylamide, 2.5% glycerol and 45 mM Tris acetate, pH 7.0) with a stacking gel (7.7% acrylamide, 1.7% agarose, 5% glycerol and 45 mM Tris acetate, pH 7.0). The fluorotagged-HS hydrolase products were separated on the separating gels (20% acrylamide, 2.5% glycerol, 0.1 M Tris base and 90 mM boric acid) with a stacking gel (7.7% acrylamide, 1.7% agarose, 5% glycerol, 0.1 M Tris base and 90 mM boric acid). Electrophoresis was carried out in the running buffer (0.1 M Trisborate, pH 8.3) at 4°C. The fluorescent images were displayed in a gel documentation system (Atto, AE-6914) and the bands of HS and CS/DS ∆-disaccharides were quantitatively analyzed by NIH Image Analyses Software using the bands of ∆di-6S and gal6S, respectively, as standards. Separately, growing cultures were treated with lead under the same conditions and the DNA content was determined by fluorometric methods 20) to express the amount of ∆-disaccharides as pmol/µg DNA. Statistical Analysis ---Data were analyzed for statistical significance by analysis of variance (ANOVA) and Bonferroni's multiple t-test. p-Values of less than 0.05 were considered to indicate statistically significant differences. Figure 1 shows the morphological appearance of growing endothelial cells after exposure to lead at 2 µM for 48 hr. Lead caused a decrease in the cell number with an appearance of spindle-shaped cells; however, no degenerative change was observed. The DNA content was also decreased by lead (from 163 ± 3.29 ng/cm 2 to 137 ± 4.62 ng/cm 2 , p < 0.01). These results agree with our previous observation that lead inhibits the proliferation of vascular endothelial cells without nonspecific cell damage. 21 ) Figure 2 shows typical gel images of FACE of disaccharide components derived from HS ( Fig. 2A) and CS/DS (Fig. 2B ) isolated from the cell layer and the conditioned medium of vascular endothelial cells before and after exposure to lead. In both the cell layer and the medium, disaccharide units of ∆-glucuronic acid (GlcA)/iduronic acid (IdoA)-N-acetylglucosamine (GlcNAc), ∆GlcA/IdoA-GlcNS and ∆IdoA(2S)-GlcNS were generated by digestion with heparitinase I and II; ∆GlcA/IdoA-GlcNS(6S) and ∆IdoA(2S)-GlcNS(6S) were also detected in the medium. These HS disaccharide units would be derived mainly from HS chains of perlecan, because bovine aortic endothelial cells predominantly synthesize and secrete perlecan as HSPGs. 22) On the other hand, ∆GlcA/IdoA-N-acetylgalactosamine (GalNAc), ∆GlcA/IdoA-6-O-sulfated GalNAc [GalNAc(6S)] and ∆GlcA/IdoA-4-O-sulfated GalNAc [GalNAc(4S)] disaccharide units were generated by digestion with chondroitinase ABC and AC II in both the cell layer and the medium; ∆GlcA/ IdoA-4-O-, 6-O-sulfated GalNAc [GalNAc(4S,6S)] was also detected in the medium. These CS/DS disaccharide units would be derived mainly from CS/ DS chains of biglycan, because only biglycan accumulates in both the cell layer and the medium as CS/DSPGs. 22) Table 1 shows the disaccharide composition of HS derived from vascular endothelial cells before and after exposure to lead. Endothelial cell HS chains accumulated in the cell layer were composed of GlcA/IdoA-GlcNAc (54.1%), GlcA/IdoA-GlcNS (33.3%) and IdoA(2S)-GlcNS (12.6%), while those accumulated in the conditioned medium were composed of GlcA/IdoA-GlcNAc (50.8%), GlcA/IdoAGlcNS (30.8%), IdoA(2S)-GlcNS (15.1%), a trace of GlcA/IdoA-GlcNS(6S) and IdoA(2S)-GlcNS(6S). The high proportion of the N-acetylated disaccharide units (GlcA/IdoA-GlcNAc) together with the low proportion of IdoA(2S)-GlcNS(± 6S) disaccharides is consistent with previous reports 7, 23, 24) where endothelial cell HS was analyzed by strong anion exchange HPLC. Lead significantly decreased the total number of HS disaccharides accumulated in both the cell layer and the conditioned medium as a result of decrease in the disaccharides of GlcA/IdoAGlcNAc, GlcA/IdoA-GlcNS and IdoA(2S)-GlcNS. Although N-and 2-O-sulfation was slightly inhibited by lead, no proportion of any disaccharide unit was affected by the metal in either the cell layer or the medium. Thus, lead-induced decrease in the amounts of disaccharide units from HS chains is regarded as a reflection of reduced perlecan synthesis by the metal. 25) In other words, lead specifically inhibits the synthesis of perlecan core protein but does not influence the HS disaccharide composition in growing vascular endothelial cells. This indicates that lead exhibits toxicity on the core protein synthesis rather than the HS formation in the process of perlecan synthesis, resulting in an induction of lower ability of endothelial cells to respond to endogenous Sparse cultures of bovine aortic endothelial cells were incubated at 37 • C for 48 hr with lead nitrate (2 µM). Digestion products separated by FACE gels (see Fig. 2 ) were quantitated using NIH image software. Values are means ± S.E. of four samples. Significantly different from the corresponding control, *p < 0.05; **p < 0.01. -, not detected. FGF-2. Table 2 shows the disaccharide composition of CS/DS derived from growing endothelial cells before and after exposure to lead. Although no marked change was observed in the cell layer, lead significantly decreased the amount of GlcA/IdoAGalNAc(6S) and GlcA/IdoA-GalNAc(4S) in the conditioned medium, resulting in a moderate decrease in the total number of CS/DS disaccharides. However, the proportion of each disaccharide unit was similar before and after exposure to lead, indicating that the metal does not influence the sulfation of GlcA/IdoA-GalNAc in the process of CS/DS chain formation. It is suggested that lead does not change the association of biglycan with endothelial cell layers, although it may moderately inhibit the biglycan synthesis.
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RESULTS AND DISCUSSION
The present data support the hypothesis that lead specifically acts on the perlecan core protein synthesis without influence upon HS chain formation in endothelial PG metabolism. Although the possibility that lead may reduce a proportion of sulfateddisaccharides in the endothelial cell perlecan via inhibition of HS sulfotranferases cannot be excluded, our conclusion is that lead-induced lower response of vascular endothelial cells to endogenous FGF-2 mainly results from a decrease in perlecan molecules of extracellular matrix as a result of selective inhibition of perlecan core protein synthesis rather than a change in the HS structure.
